16.12
price down icon3.47%   -0.58
after-market Handel nachbörslich: 16.00 -0.12 -0.74%
loading

Finanzdaten der Immunovant Inc-Aktie (IMVT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
9.92%
127.22
115.74 94.28 80.88 61.55
Income/Loss From Continuing Operations Before Tax
9.78%
-119.70
-109.04 -87.07 -75.09 -51.53
Income Tax Expense/Benefit
1,071%
0.913
0.078 0.077 0.232 -0.108
Income/Loss From Continuing Operations After Tax
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Net Income/Loss
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Diluted Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Basic Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Diluted Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):